Followers | 198 |
Posts | 11848 |
Boards Moderated | 6 |
Alias Born | 06/20/2022 |
Friday, February 23, 2024 10:22:11 AM
Recent MNPR News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 01:02:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 01:01:12 PM
- Monopar Therapeutics Reports Third Quarter 2024 Financial Results and Recent Developments • GlobeNewswire Inc. • 11/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:05:20 PM
- Monopar Therapeutics Inc. Announces Closing of $19.2 Million Public Offering of Common Stock • GlobeNewswire Inc. • 10/30/2024 05:42:48 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/29/2024 08:05:31 PM
- Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock • GlobeNewswire Inc. • 10/29/2024 01:15:08 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/28/2024 08:04:02 PM
- Monopar Therapeutics Inc. Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 10/28/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 11:00:40 AM
- Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate • GlobeNewswire Inc. • 10/24/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/22/2024 12:00:17 PM
- Monopar Presents Encouraging Human Clinical Dosimetry Data on its uPAR Program at EANM 2024 • GlobeNewswire Inc. • 10/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 12:00:09 PM
- Monopar Expands Radiopharma Intellectual Property Portfolio with Patent Filing on New Compounds and Linkers • GlobeNewswire Inc. • 10/15/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 12:00:20 PM
- Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers • GlobeNewswire Inc. • 10/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 11:45:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 11:44:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 12:00:10 PM
- Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr • GlobeNewswire Inc. • 09/12/2024 12:00:00 PM
- Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:07:29 PM
- Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule • GlobeNewswire Inc. • 08/27/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 12:00:13 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM